Trial intelligence / Profile preview

Tranexamic acid injection to reduce postoperative edema, bleeding, and ecchymosis in rhinoplasty

IRCT20250605066067N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tranexamic acid in rhinoplasty, sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Postoperative edema, Postoperative bleeding and 1 more. Started Jun 2025; status: completed.

02

Drugs

tranexamic acid
03

Conditions

rhinoplasty

Beyond the preview

Go deeper on IRCT20250605066067N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250605066067N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call